Conference Program
NEW! Speaker presentations are posted on this page. An archive of the conference webcast is also available for viewing: Webcast
To download files, right click and select "save target as" to your desktop or other folder.
Monday, April 10
- Registration and light refreshments, 8:00 am
- Opening Remarks, 8:45 am
- Arthur Heuer, PhD, DSc, Case Western Reserve University
- John Anderson, PhD, Case Western Reserve University
- William Wulf, PhD, National Academy of Engineering
- A National Perspective on Pandemic Influenza Preparedness, 9:00 am
- Bruce Gellin, MD, MPH,
Director National Vaccine Program Office
Department of Health and Human Services
- Keynote Address, 9:15 am
Pandemic Influenza: A Global Perspective, - Klaus Stöhr, PhD, Head, WHO Influenza Team
- Presentation (Adobe PDF, 747 KB)
- Keynote Address, 10:15 am
Scientific Methods Underpinning Policy Formulation for an Influenza Pandemic, - Roy Anderson, FRS, FMEDSCI
Professor of Epidemiology, Imperial College, London, UK - Presentation (MS PPT, 23 MB)
- Break, 11:10 - 11:30 am
- Accelerated Introduction of Pharmaceuticals: The Baseline, 11:30 am
- Patrick Scannon, MD, PhD
Chief Scientific and Medical Officer, Xoma, Ltd. - Presentation (MS PPT, 3.6 MB)
- Presentation in Adobe PDF (PDF, 1.1 MB)
- Lunch, 12:00 - 1:15 pm
- Egg-based Influenza Vaccine Production - 30 Years of Commercial Experience and our Future Expectations for Cell Culture, 1:15 pm
- James T. Matthews, PhD
Senior Director, Public Policy, Science and Health Policy,
sanofi pasteur, US - Presentation (MS PPT, 12.9 MB)
- Cell-culture based Vaccine Production: Technological Options, 2:00 pm
- Rino Rappuoli, PhD
Chief Scientist, Chiron Vaccines Research - Presentation (MS PPT, 16.5 MB)
- Cell-culture based Vaccine Production: Engineering Bottlenecks, 2:30 pm
- Etienne Malhaise
Manager of TS Process Biotech, GSK Biologicals - Presentation (MS PPT, 2.3 MB)
- Regulation of Vaccines: Challenges and Opportunities, 3:00 pm
- Norman W. Baylor, PhD
Director, Office of Vaccines Review and Research, CBER
Food and Drug Administration - Presentation (MS PPT, 508 K)
- Break, 3:40 - 4:00 pm
- Panel Discussion, 4:00 - 5:00 pm
- Gary Taubes, Moderator
- Reception, 5:00 - 6:00 pm
Tuesday, April 11
- Registration, 8:00 am
- Opening Remarks, 8:25 am
- Surge-capable Peptide Therapeutics and Vaccines, 8:30 am
- Michael Callahan MD, DTM&H
Division of Infectious Diseases, Massachusetts General Hospital
Program Manager, Avian Influenza Surveillance, U.S. Dept of State, Office of Cooperative Threat Reduction and Defense Science Office/DARPA - Presentation (MS PPT, 4.9 MB)
- Alternative Methods of Vaccine Production, 9:00 am
- Alan Shaw
President and CEO, VaxInnate - Presentation (MS PPT, 3.8 MB)
- A High-Volume, Cost-Effective Microparticle-Based Vaccine Production Process, 9:45 am
- William L. Warren, PhD
CEO, VaxDesign Corporation - Presentation (MS PPT, 8.5 MB)
- Migration of Monocytes in a Collagen Cushion (Windows Media File, 4.8 MB)
- VaxDesign AIS model (Windows Media File, 5.8 MB)
- A Microbial Expression System as a Possible Route to Antigen Production for Use as Vaccines, 10:15 am
- Lada Rasochova, PhD, R&D Group Leader
Dowpharma - Vaccines - Presentation (MS PPT, 15.6 MB)
- Break, 10:45 - 11:15 am
- Facility Design & Operational Considerations for the Implementation of Single-Use Disposables in Pandemic Influenza Vaccine Manufacturing, 11:15 am
- Kim Nelson, PhD
Senior Associate and Director, Biopharm Services, CRB Consulting Engineers - Presentation (MS PPT, 20 MB)
- Downstream Issues: Vaccine Formulation and Sterile Filling Issues, 11:45 am
- Shawn Knopp, PhD
Project Manager, Baxter BioPharma Solutions - Michael J. Akers, PhD
Senior Director, Pharmaceutical Research and Development,
Baxter BioPharma Solutions - Presentation (MS PPT, 13.9 MB)
- Baxter BioPharma Solutions Manufacturing (Windows Media File, 25 MB)
- Lunch, 12:15 - 1:30 pm
- Paving the Way to Process Understanding: Improving Manufacturing Performance, and Developing Quality Excellence by using Process Analytical Technology (PAT) in Vaccine Production, 1:30 pm
- Ingrid Maes
Consultant, Innovative Technologies
Siemens AG, Competence Center Pharmaceutics - Presentation (MS PPT, 4 MB)
- Adapting Industry Practice for Rapid, Large Scale Manufacture of Pharmaceutical Proteins, 2:00 pm
- David Estell, PhD
Vice President of Technology, Genencor International - Presentation (MS PPT, 912 K)
- Development of a Low Cost Fermentation and Recovery Process for a Commodity Polymer: Nodax™ Polyhydroxyalkanoate, 2:30 pm
- Phillip R. Green, PhD
Procter & Gamble Chemical - Presentation (MS PPT, 576 K)
- Accelerated Introduction of Materials in the Aerospace Industry, 3:00 pm
- S. Eric Cregger
Associate Technical Fellow, The Boeing Company - Presentation (MS PPT, 6.2 MB)
- Break, 3:30 - 4:00 pm
- Panel Discussion: Next Steps, 4:00 pm
- Gary Taubes, Moderator